
70% Remission for Postpartum Depression? The Psychedelic Breakthrough
30/4/2026
0:00
35:54
Postpartum depression treatment advances with psychedelic therapy. Greg Mayes of Reunion Neuroscience discusses luvesilocin drug development. This episode explores how shorter-acting psilocybin analogs offer new hope for mothers. Greg highlights the success of the RECONNECT study and the path to FDA breakthrough designation.
Otros episodios de "Power to the Patients"



No te pierdas ningún episodio de “Power to the Patients”. Síguelo en la aplicación gratuita de GetPodcast.








